Press Release June 26, 2021Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma (idecabtagene vicleucel) for Relapsed and Refractory Multiple Myeloma 0 0 Share
Company Ticker News June 24, 2021Bristol Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know 0 0 Share
Company Ticker News June 22, 2021Bristol Myers' (BMY) Onureg Gets European Commission Approval 0 0 Share
Company Ticker News June 20, 2021Bristol-Myers (BMY) Partners Eisai for Antibody Drug Conjugate 0 0 Share
Press Release June 20, 2021Bristol Myers Squibb Receives European Commission Approval for Onureg® (azacitidine tablets) as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia 0 0 Share
Company Ticker News June 20, 2021Bristol Myers Onureg Scores European Approval As Maintenance Therapy For Acute Myeloid Leukemia 0 0 Share
Company Ticker News June 20, 2021Bristol Myers Inks Licensing Pact For Eisai's Folate Receptor ADC Drug, Lays Out Over $3B For Rights 0 0 Share
